Roche Acquires Foundation Medicine For $137 Per Share Or $2.4B
June 19, 2018 at 09:10 AM EDT
Roche and Foundation Medicine announced they have entered into a definitive merger agreement for Roche to acquire the outstanding shares of Foundation Medicine not already owned by Roche and its affiliates at a price of $137.00 per share in cash.
